This transaction is a great example of the coming trend of consolidation amongst healthcare delivery leaders...
Chicago, IL (PRWEB) December 06, 2016
Ziegler, a specialty investment bank, is pleased to announce its role in advising Telcare, Inc. (Telcare) in its recent acquisition by BioTelemetry, Inc. Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system. Following this initial success, Telcare has focused on providing a comprehensive suite of offerings to support diabetes management, combining a connected glucometer, cloud-based analytics and care management tools that enhance care relative to the status quo.
BioTelemetry, headquartered in Malvern, P.A. and formerly known as CardioNet, Inc., is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices and centralized cardiac core laboratory services.
The strategic combination will increase BioTelemetry’s presence in the large and rapidly growing digital population health management market. Telcare’s Blood Glucose Monitoring (“BGM”) system transmits real-time results to a cloud-based analytical engine, which synthesizes data, monitors trends and provides caregivers with critical information about patients’ health status and the potential need to intervene. Given BioTelemetry’s clear leadership position in the analysis and transmission of complex digital health information, the company is uniquely positioned to accelerate the market penetration of Telcare’s digital population health management solution. BioTelemetry chose the diabetes market as its first major digital population health acquisition because of its significant overall burden on the healthcare system, with estimated direct annual costs in the U.S. of over $245 billion.
The Ziegler team, comprised of lead banker Grant Chamberlain with support from Adam Heller, Kari O’Brien and Jenny Poth, represented Telcare in helping prepare and market to potential acquirers and ultimately advised on and facilitated the transaction between Telcare and BioTelemetry.
CEO of Telcare, Paula LeClair, shared her experience using Ziegler as an advisor. “Ziegler was a truly value-added advisor in this transformative transaction and they remained a trusted source for guidance throughout the entire sale process. Their assistance in positioning the opportunity and connecting Telcare with like-minded strategic organizations was instrumental to facilitating a successful transaction with BioTelemetry. We are very excited to join the BioTelemetry team and look forward to driving the future of connected diabetes care.”
Grant Chamberlain, Managing Director in Ziegler's corporate finance healthcare practice, commented, “This transaction is a great example of the coming trend of consolidation amongst healthcare delivery leaders. Telcare and BioTelemetry represent two sector leaders in adjacent disease states that recognize the importance of all-encompassing chronic care management to improve outcomes and reduce costs. With the addition of Telcare’s CEO, Paula LeClair, BioTelemetry is gaining one of the foremost thought leaders in the diabetes sector, who, alongside BioTelemetry’s CEO, Joe Capper, is well positioned to transform the diabetes care delivery model and provide the critical missing ingredient necessary to close the time and distance gaps endemic in traditional care management programs.”
Ziegler's Corporate Finance practice is focused on delivering best-in-class advisory and financing solutions for companies and organizations across the healthcare industry. In our core practice areas of healthcare services, information technology, hospitals and senior living, Ziegler is one of the most active M&A firms offering innovative sell-side, buy-side, recapitalization/restructuring, equity private placement and strategic partnering services.
For more information about Ziegler, please visit us at http://www.Ziegler.com.
The Ziegler Companies, Inc., together with its affiliates (Ziegler), is a privately held, specialty investment bank with unique expertise in complex credit structures and advisory services. Nationally, Ziegler is ranked as one of the leading investment banking firms in its specialty sectors of healthcare, senior living, religion, and education, as well as general municipal and structured finance. Headquartered in Chicago, IL with regional and branch offices throughout the U.S., Ziegler provides its clients with capital raising, corporate finance, FHA/HUD, strategic advisory services and research. Ziegler serves institutional and individual investors through its wealth management and capital markets distribution channels.
Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client’s experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.
# # #